Homepage2096 • HKG
add
Simcere Pharmaceutical Group Ltd
Vorige slotkoers
$Â 12,26
Dag-range
$Â 11,84 - $Â 12,62
Jaar-range
$Â 5,08 - $Â 13,22
Beurswaarde
31,03Â mld. HKD
Gem. volume
13,67Â mln.
Koers/winst
39,30
Dividendrendement
1,37%
Primaire beurs
HKG
Marktnieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
(CNY) | dec 2024info | Wijziging j-o-j |
---|---|---|
Opbrengst | 1,76Â mld. | 9,16% |
Bedrijfskosten | 1,16Â mld. | 11,70% |
Netto inkomsten | 138,28Â mln. | 117,74% |
Netto winstmarge | 7,85 | 116,25% |
Winst per aandeel | — | — |
EBITDA | 332,68Â mln. | 45,24% |
Effectief belastingtarief | 14,95% | — |
Balans
Totale activa
Totale passiva
(CNY) | dec 2024info | Wijziging j-o-j |
---|---|---|
Contanten en kortetermijnbeleggingen | 1,94Â mld. | -3,73% |
Totale activa | 11,51Â mld. | 6,05% |
Totale passiva | 4,44Â mld. | 22,33% |
Totaal aandelenvermogen | 7,07 mld. | — |
Uitstaande aandelen | 2,49 mld. | — |
Koers-boekwaardeverhouding | 4,32 | — |
Rendement op activa | 5,98% | — |
Rendement op kapitaal | 8,31% | — |
Kasstroom
Nettomutatie in liquide middelen
(CNY) | dec 2024info | Wijziging j-o-j |
---|---|---|
Netto inkomsten | 138,28Â mln. | 117,74% |
Operationele kasstroom | 264,23Â mln. | 126,82% |
Kasstroom uit beleggingen | -324,06Â mln. | -145,23% |
Kasstroom uit financiering | -346,97Â mln. | -69,06% |
Nettomutatie in liquide middelen | -405,96Â mln. | -84,55% |
Vrije kasstroom | -47,01Â mln. | 78,58% |
Over
Simcere Pharmaceutical Group or Simcere Pharmaceutical is a manufacturer and supplier of branded generic pharmaceuticals in the Chinese market. Its focus is to introduce generic and pharmaceutical products for the treatment of diseases with high incidence and/or mortality rate. The company has introduced a generic anti-stroke medication under the brand name, Bicun, and an anti-cancer medication under the brand name, Endu. Its products include antibiotics, anti-stroke medications, anti-inflammatory drugs, anti-cancer medications and other medicines. In addition, it has obtained approvals from the China State Food and Drug Administration to manufacture and sell over 210 other products. Wikipedia
CEO
Opgericht
1995
Hoofdvestiging
Website
Werknemers
6.584